MAIA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 36.98%

Insider Buying (Last 12 Months): $249,878.80

Insider Selling (Last 12 Months): $0.00

MAIA Biotechnology Insider Trading History Chart

MAIA Biotechnology Share Price & Price History

^$2.86

▲ +0.18 (6.72%)

As of 04/26/2024 02:14 PM ET

Days: 30 | 90 | 365

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

MAIA Biotechnology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2024	Stan Smith	Director	Buy	170,940	$1.17	$199,999.80	857,568
5/18/2023	Ramiro Guerrero	Director	Buy	1,200	$2.47	$2,964.00	312,672
5/15/2023	Cristian Luput	Director	Buy	3,000	$2.63	$7,890.00	298,068
4/28/2023	Vlad Vitoc	CEO	Buy	4,000	$2.50	$10,000.00	809,121
4/27/2023	Joseph F Mcguire	CFO	Buy	4,400	$2.25	$9,900.00	9,400
4/27/2023	Ramiro Guerrero	Director	Buy	8,500	$2.25	$19,125.00	311,472
4/20/2023	Stan Smith	Director	Buy	10,000	$3.74	$37,400.00	553,328
4/17/2023	Cristian Luput	Director	Buy	1,576	$3.69	$5,815.44	295,068
4/13/2023	Cristian Luput	Director	Buy	622	$3.62	$2,251.64	292,690
4/3/2023	Vlad Vitoc	CEO	Buy	1,375	$3.50	$4,812.50	804,196
3/30/2023	Vlad Vitoc	CEO	Buy	205	$3.43	$703.15	801,326
3/24/2023	Stan Smith	Director	Buy	938	$3.49	$3,273.62	543,328
3/22/2023	Stan Smith	Director	Buy	1,458	$3.18	$4,636.44	540,528
3/20/2023	Stan Smith	Director	Buy	3,006	$3.28	$9,859.68	536,334
3/16/2023	Ramiro Guerrero	Director	Buy	1,333	$3.64	$4,852.12	301,709
3/13/2023	Cristian Luput	Director	Buy	3,000	$4.07	$12,210.00	292,068
3/10/2023	Ramiro Guerrero	Director	Buy	443	$3.98	$1,763.14	300,376
3/8/2023	Stan Smith	Director	Buy	3,076	$4.20	$12,919.20	529,746
3/8/2023	Vlad Vitoc	CEO	Buy	1,581	$4.21	$6,656.01	801,121
3/6/2023	Stan Smith	Director	Buy	4,594	$4.39	$20,167.66	524,709
3/6/2023	Vlad Vitoc	CEO	Buy	544	$4.24	$2,306.56	798,101
3/3/2023	Stan Smith	Director	Buy	2,509	$4.43	$11,114.87	520,115
3/2/2023	Vlad Vitoc	CEO	Buy	45	$4.42	$198.90	795,159
3/1/2023	Stan Smith	Director	Buy	198	$4.48	$887.04	517,583
2/28/2023	Vlad Vitoc	CEO	Buy	1,275	$4.49	$5,724.75	794,832
2/27/2023	Stan Smith	Director	Buy	219	$4.47	$978.93	515,766
2/21/2023	Stan Smith	Director	Buy	228	$4.49	$1,023.72	514,474
2/17/2023	Vlad Vitoc	CEO	Buy	73	$4.25	$310.25	793,557
2/16/2023	Stan Smith	Director	Buy	62	$4.25	$263.50	514,171
2/15/2023	Vlad Vitoc	CEO	Buy	10	$4.25	$42.50	793,474
2/14/2023	Stan Smith	Director	Buy	198	$4.25	$841.50	514,099
2/10/2023	Stan Smith	Director	Buy	337	$4.25	$1,432.25	513,901
2/10/2023	Vlad Vitoc	CEO	Buy	343	$4.24	$1,454.32	793,464
1/25/2023	Stan Smith	Director	Buy	9	$4.25	$38.25	513,337
1/13/2023	Cristian Luput	Director	Buy	504	$3.88	$1,955.52	278,572
1/3/2023	Vlad Vitoc	CEO	Buy	2,324	$3.64	$8,459.36	791,855
12/27/2022	Stan Smith	Director	Buy	604	$3.38	$2,041.52	510,091
12/22/2022	Stan Smith	Director	Buy	731	$3.34	$2,441.54	508,506
12/20/2022	Stan Smith	Director	Buy	4,048	$3.53	$14,289.44	507,376

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for MAIA Biotechnology (NYSEAMERICAN:MAIA)

5.65% of MAIA Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

MAIA Biotechnology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/10/2023	FNY Investment Advisers LLC	17,550	$38K	0.0%	N/A	0.129%
7/20/2023	Naviter Wealth LLC	22,168	$49K	0.0%	N/A	0.163%
2/7/2023	Lynwood Capital Management Inc.	250,000	$0.88M	1.1%	+25.1%	2.283%
1/4/2023	Centric Wealth Management	40,206	$0.14M	0.1%	N/A	0.367%

Data available starting January 2016

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.

Today's Range

Now: $2.86

$2.65

$2.91

50 Day Range

MA: N/A

52 Week Range

Now: $2.86

$0.82

$3.07

Volume

222,967 shs

Average Volume

382,506 shs

Market Capitalization

$58.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of MAIA Biotechnology?: MAIA Biotechnology's top insider investors include:
Stan Smith (Director)
Vlad Vitoc (CEO)
Ramiro Guerrero (Director)
Cristian Luput (Director)
Joseph F Mcguire (CFO)
Learn More about top insider investors at MAIA Biotechnology.